Robert Weinkove

Robert Weinkove

Malaghan Institute of Medical Research - / New Zealand
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4687322
person_outline Robert Weinkove's MOST POPULAR ARTICLES
1-) Venetoclax and obinutuzumab in patients with CLL and coexisting conditions K Fischer, O Al-Sawaf, J Bahlo, AM Fink, M Tandon, M Dixon, S Robrecht, ... New England Journal of Medicine 380 (23), 2225-2236, 2019 5822019
2-) Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open …O Al-Sawaf, C Zhang, M Tandon, A Sinha, AM Fink, S Robrecht, ...The Lancet Oncology 21 (9), 1188-1200, 20202032020
3-) Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerationsR Weinkove, P George, N Dasyam, AD McLellanClinical & translational immunology 8 (5), e1049, 20192022019
4-) Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemiaJR Brown, B Eichhorst, P Hillmen, W Jurczak, M Kaźmierczak, ...New England Journal of Medicine 388 (4), 319-332, 20232922023
5-) Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidanceR Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, ...Medical Journal of Australia 212 (10), 481-489, 20201672020